Biote

Biote is a leading innovator in precision and preventive medicine, specializing in hormone optimization and therapeutic wellness. Founded in 2012, the company focuses on addressing the earliest indicators of aging through its Biote Method, which involves bioidentical hormone replacement therapy (BHRT) using subcutaneous pellets. Biote has trained over 7,100 medical practitioners nationwide, who have performed over 4 million pellet insertions, providing a convenient solution to a large patient population experiencing hormone imbalance.

Biote operates a high-growth, differentiated medical practice-building business, empowering practitioners to establish and successfully operate hormone optimization centers. The company provides the necessary components, training, and support to ensure practitioners can effectively identify and treat early indicators of hormone-related aging conditions. Biote's commitment to research and education drives innovation and aims to change the way healthcare is practiced through hormone optimization and precision medicine.

Biote's mission is to revolutionize healthcare through hormone optimization and precision and preventative medicine. They believe in healthy aging and empower both patients and healthcare providers to take control of their health through personalized treatment options. They offer training programs to help clinicians identify and address early indicators of aging, and provide patients with custom-compounded hormone pellets to restore balance and enhance overall well-being.

Biote promotes a culture focused on patient-centered care, emphasizing personalized treatment plans and individualized attention. They prioritize precision and preventative medicine, empowering both patients and providers to take control of their health through hormone optimization. This translates into a culture that values innovation, ongoing education, and a commitment to improving healthcare outcomes through a combination of scientific research and real-world experience.